NCT00334139View on ClinicalTrials.gov

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

411

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Prostate CancerBreast CancerBone Metastasis
Interventions
DRUG

Zoledronic Acid

every 4 weeks for 4 months

Trial Locations (1)

Unknown

Novartis Investigative Site, Ulm

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY